drugset / Trial / NCT05167617

Vitamin D Improves Clinical Manifestations in Asthmatic Children

NCT05167617 ↗

Phase 1 Completed 102 enrolled Tanta University
NaSingle-groupOpen-labelSupportive care

Summary

Objectives: Evaluation of the effect of vitamin D supplemental therapy (VDST) on clinical manifestation of bronchial asthma (BA) as judged by The International Study of Asthma and Allergies in Childhood (ISAAC) questionnaire and estimated serum levels of immunoglobulin E (IgE). Patients \& Methods: scores of ISAAC questionnaire and blood samples were obtained for estimation of serum IgE and 25-hydroxy VD (25-HVD) at booking time (T1) of 102 BA patients. VDST was provided as 2000 IU daily for 3 and 6 months for patients had moderate and mild HVD, respectively. At the end of 12-m after start of VDST (T2), ISAAC questionnaire and serum levels of 25-HVD and IgE were re-evaluated and the percentage of change was calculated.

Timeline

Start
2020-06-01
Primary completion
2021-07-21
Completion
2021-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Vit D Unknown 2000 iu —